Finding drugs for breast cancer targets
A scientist at the University of Houston receives a $2 million grant to innovate computer-aided drug discovery for breast cancer.
List view / Grid view
A scientist at the University of Houston receives a $2 million grant to innovate computer-aided drug discovery for breast cancer.
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
Researchers have developed a new way to generate breast tumour models faster, more reliably and with less immune variability than existing models.
Researchers at the University of Texas have redesigned a key component of a CRISPR-based gene-editing tool.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.
Scientists have gained deeper knowledge about the mislocalisation of a protein, providing a possible therapeutic target that could have implications in treating dementia.
Researchers have developed a new imaging approach that can capture blood vessel images at different spatial scales.
New research from the Karolinska Institutet shows that RNA molecules have a much broader function in the development of cancer.
A new study has revealed a cannabidiol analogue can possibly prevent neuropathic pain induced by chemotherapy, as well as being beneficial against cancer.
A new study modelled chlamydia and HPV co-infection in patient-derived ectocervix organoids to reveal distinct cellular reprogramming.
Scientists have demonstrated how automated, high-throughput life science experiments can be replicated on a modest budget.
A study has shown how Parkinson’s disease may be driven by cell stress-related biochemical events that disrupt a key cellular clean-up system.
Researchers at the US National Heart, Lung, and Blood Institute have discovered new insights about lymphangioleiomyomatosis, a rare lung disease that affects about one in 200,000 Americans.
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.
A new report says that the global lab automation market is set to grow significantly until 2031, due to advanced drug development.